Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tadej Battelino
Healthpartners Institute, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
DreaMed Diabetes (https://dreamed-diabetes.com)
Salary not from the awardee Institution
please see attached conflict of interest management plan
Home Use of MD-Logic Automated Insulin Delivery System: Safety and Efficacy
Studies have shown that devastating complications related to type 1 diabetes (T1D) can be reduced through tight blood glucose control. However, increased risks related to hypoglycemia and limitations in glucose monitoring and insulin administration technologies make tight glucose control difficult to achieve. This proposed research evaluates portable/wearable technologies to measure glucose levels and adjust delivery of insulin through a promising and novel automated closed-loop artificial pancreas (AP) system called MD- Logic. Automated Insulin Delivery (MD-Logic) has been demonstrated to be safe and effective in preliminary robust published trials. This research project, called MD2Go, will generate the data necessary to address the safety, reliability, and efficacy of this AP system in the real-world setting. The study design incorporates features needed for an approvable study by the U.S. Food and Drug Administration (FDA) as determined from several pre-submission FDA meetings. The results will significantly advance AP technology closer to commercial feasibility, a feat that could improve the quality of life and burden of disease for millions of children, adolescents, and adults living with T1D.
Filed on September 18, 2018.
Tell us what you know about Tadej Battelino's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Tadej Battelino”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Tadej Battelino | Healthpartners Institute | Conflict of Interest | DreaMed Diabetes (https://dreamed-diabetes.com) | Value cannot be readily determined |
| Tadej Battelino | Healthpartners Institute | Conflict of Interest | DreaMed Diabetes (https://dreamed-diabetes.com) | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.